NCT01124123View on ClinicalTrials.gov

Oral Bioavailability of Bilastine

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

September 30, 2010

Conditions

Healthy

Interventions

DRUG

Bilastine

20 mg oral tablet

DRUG

Bilastine

10 mg endovenous bilastine

Trial Locations (1)

31008

Unidad de Investigacion Clinica. Clinica Universidad de Navarra, Pamplona

Sponsors

Lead Sponsor

Faes Farma, S.A.

All Listed Sponsors

lead

Faes Farma, S.A.

INDUSTRY

NCT01124123 - Oral Bioavailability of Bilastine | Biotech Hunter | Biotech Hunter